News
Eric Green, M.D., Ph.D., formerly the NHGRI director, has been awarded by Fierce Pharma as a Fierce 50 Innovation Honoree. The Fierce 50 is designed to honor the 50 most influential leaders and organizations shaping the future of biopharma, healthcare, and life sciences. The Fierce editorial team
Inventors at the National Cancer Institute’s Laboratory of Molecular Biology have isolated three anti Programed Death-Ligand 1 (PD-L1) single domain antibodies that can be used as a therapeutic for treating solid tumors. An imbalance of PD-L1 contributes to cancer immune escape and it has been
Technology Transfer Central has selected Joseph M. Conrad, Ph.D. from the National Cancer Institute’s Invention Development and Marketing Unit (IDMU) to present a webinar focused on strategies to revitalize and expand a high-touch, low-tech approach to marketing technologies. This webinar will
NIH inventor Carolina Barillas-Mury, M.D., Ph.D., has been elected into the National Academy of Medicine (NAM) this year. The NAM is made up of over 2,000 elected members from around the globe who give scientific and policy guidance relating to human health. This honor is one of the highest that can